
Nano-X Imaging (NNOX) Stock Forecast & Price Target
Nano-X Imaging (NNOX) Analyst Ratings
Bulls say
Nano X Imaging Ltd reported a quarterly revenue increase to $3.4 million, an improvement from $3.0 million in the previous quarter, attributed to enhanced teleradiology utilization and improved margins. The company has established a distribution agreement with Imperial Imaging Technology to expand its Nanox.ARC system across six Southeast states, which is expected to augment its market presence in a region with significant demand for orthopedic and musculoskeletal imaging. Additionally, management reaffirmed its target to surpass 100 deployed units globally by year-end and projected a revenue guidance of $35 million for 2026, indicating strong confidence in future growth and the successful execution of its strategic roadmap.
Bears say
Nano X Imaging Ltd reported a significant decrease in cash reserves, declining to $55.5 million from $83.2 million at the end of the previous year, primarily due to an operating cash burn of $30.4 million and modest use of its at-the-market (ATM) facility. The company continues to face challenges, evidenced by an elevated GAAP gross loss of $2.9 million and a stable net loss of $13.7 million, highlighting ongoing investments in system deployments and AI infrastructure. Furthermore, the anticipated timelines for development, regulatory approval, and commercialization have consistently exceeded initial expectations, necessitating greater investments and contributing to a negative outlook on the stock.
This aggregate rating is based on analysts' research of Nano-X Imaging and is not a guaranteed prediction by Public.com or investment advice.
Nano-X Imaging (NNOX) Analyst Forecast & Price Prediction
Start investing in Nano-X Imaging (NNOX)
Order type
Buy in
Order amount
Est. shares
0 shares